clindamycin eql pharma hart hylki 150 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 150 mg
clindamycin eql pharma hart hylki 300 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 300 mg
dalacin stungulyf, lausn 150 mg/ml
pfizer aps - clindamycinum fosfat - stungulyf, lausn - 150 mg/ml
dalacin hart hylki 150 mg
pfizer aps - clindamycinum hýdróklóríð - hart hylki - 150 mg
dalacin hart hylki 300 mg
pfizer aps - clindamycinum hýdróklóríð - hart hylki - 300 mg
dalacin leggangakrem 20 mg/g
pfizer aps - clindamycinum fosfat - leggangakrem - 20 mg/g
dalacin húðfleyti 10 mg/ml
pfizer aps - clindamycinum fosfat - húðfleyti - 10 mg/ml
duac hlaup
stiefel laboratories legacy (ireland) ltd - benzoylis peroxidum; clindamycinum fosfat - hlaup
sivextro
merck sharp & dohme b.v. - tedizólíð fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.
neptra
bayer animal health gmbh - florfenicol, terbinafin stutt og long-term, mometasone furoate - otologicals, krefur og antiinfectives í samsetning - hundar - fyrir meðferð bráð hundur bólgu í ytra eða bráð tilvikum endurtekin eyrnabólga af völdum blandað sýkingar næm stofnum bakteríur viðkvæm florfenicol (Þegar pseudintermedius) og sveppi viðkvæm terbinafin (malassezia pachydermatis).